Clinical Trial Update: Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the combination of ribociclib, everolimus, and dexamethasone for relapsed acute lymphoblastic leukemia (ALL) is activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Everolimus (everolimus)
• Ribociclib (ribociclib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Lymphoblastic Leukemia ALL | Phase 1 | Status: ACTIVE_NOT_RECRUITING